By Anjali Sharma UNITED NATIONS – UN agencies on Monday reported that at least 15 people have been killed in Nepal, and over 100 injured, in large-scale youth protests that...
Read More
Dr. Priyanka Singh, Assistant Professor at BHU, honoured with Sharada Centenary Award 2025. 12 years of teaching, 3 published books, 35+ research papers presented nationally & internationally. Expertise in epigraphy,...
Read More
President Murmu addresses Platinum Jubilee of EEPC India in New Delhi. Engineering exports rose from USD 70 billion to USD 115 billion in the past decade. EEPC praised for connecting...
Read More
India and Israel sign Bilateral Investment Agreement (BIA) in New Delhi. Signed by Nirmala Sitharaman and Bezalel Smotrich. Provides investor protection, arbitration-based dispute resolution, and safeguards against expropriation. GG News...
Read More
Date & Venue: 15–17 September 2025, Kolkata, West Bengal. Theme: ‘Year of Reforms – Transforming for the Future’. Inauguration: By Prime Minister Narendra Modi. Focus: Reforms, transformation, change, and operational...
Read More
Supreme Court allows Aadhaar as 12th valid document for voter verification in Bihar. Aadhaar will not serve as proof of citizenship. Election Commission directed to issue instructions to officials. Authority...
Read More
Scindia met Japan’s Masashi Adachi at the Universal Postal Congress in Dubai. Talks focused on digital innovation and strengthening postal networks. India Post and Japan Post to collaborate on technology-driven...
Read More
Vice President election voting between NDA’s C.P. Radhakrishnan and opposition’s Justice B. Sudarshan Reddy. BJD and BRS to abstain, citing “equal distance” and lack of NOTA option. Abstention likely to...
Read More
Harshita Rai On September 9, the nation will watch closely as Members of Parliament cast their votes to elect India’s next Vice President. It may not be a direct election...
Read More
India recorded 1.6 million new cancer cases and 900,000 deaths in 2024. Russia develops mRNA-based cancer vaccine EnteroMix. Phase 1 trial shows 100% safety and effectiveness. Vaccine is personalized based...
Read More